4 ms·
”Determining whether something is (non) malignant isn't trivial. It often requires a more invasive test (e.g., biopsy, exploratory surgery)” Not necessarily, w
by Someone 8y ago
”Determining whether something is (non) malignant isn't trivial. It often requires a more invasive test (e.g., biopsy, exploratory surgery)”
Not necessarily, waiting can in many cases tell you whether something is malignant. If we had, say, a century of monthly full-body MRIs of a million persons, together with their history and cause of death, the technology to align those scans across time, and the technology to analyze such a data set, a retrospective cohort study (https://en.wikipedia.org/wiki/Retrospective_cohort_study https://en.wikipedia.org/wiki/Retrospective_cohort_study) probably could uncover quite some interesting and useful information.
If, at every step, you pick the option with the highest expected QALYs (https://en.wikipedia.org/wiki/Quality-adjusted_life_year https://en.wikipedia.org/wiki/Quality-adjusted_life_year), and you manage to make doing the MRI very efficient, I think doing that experiment even might pass an ethics committee (at the cost of making the analysis harder)
(might because one could argue that the patient would be better of if the money spent doing those MRIs were spent on something else)
Unfortunately, doing such an experiment isn’t practical (¿yet?).
- mattkrause 8y agoTwo reasons I think this is not the way to go: First, the cost would be insane. A century of monthly MRIs is 1200 scans per person, or 1.2B scans to finish your hypothetical dataset. We pay about $US 550/hr for scanner time, using a research scanner that's subsidized (i.e., we're just covering costs, not making a profit). The article doesn't say how long the scan is. You can burn as much scanner time as you want chasing resolution/quality, but an hour seems reasonable. That comes out to $660B, which is...a lot, and we haven't even paid staff yet! Second, we have sorta tried this already. There's a massive neuroscience project to scan tons of brains called the Human Connectome Project. They have 1200 subjects, some scanned multiple times, behavioral measures, health outcomes, the works.... People have certainly found stuff in the data (I'm using some of it right now), but it hasn't lead to wild breakthroughs. There's a ongoing debate about whether this money would have been better spent on hypothesis-driven research instead.
- briandear 8y agoAt that scale, scans wouldn’t cost $550 per hour. “Because it’s too expensive,” seems like a great opportunity for some clever startup to figure out a way to make it less expensive. Computers used to take up entire rooms. Flying across the country used to be insanely expensive. Cell phones used to cost a ton of money per minute. Reducing the cost of scanning, or developing entirely new scanning tech isn’t science fiction, it’s the future.
- D_Alex 8y ago$98/scan in Japan. https://www.pbs.org/wgbh/pages/frontline/sickaroundtheworld/interviews/ikegami.html https://www.pbs.org/wgbh/pages/frontline/sickaroundtheworld/...
- mattkrause 8y agoThe doctor gets $98. The $550/hr price I quoted is for a research scanner where no one is even trying to turn a profit; they just want to pay off the machine and its operating costs. The machines themselves are not magically cheaper in Japan; they're just being paid for through some other route. If the scanner were somehow free (gov't grant?), 98$ seems pretty reasonable for the labor.
- flemhans 8y ago$105 in Romania then, for most body parts. <http://www.hiperdia.ro/servicii-medicale/> http://www.hiperdia.ro/servicii-medicale/>
- mattkrause 8y agoAgain, that’s what you pay (near as I can tell), but that’s not what it costs. They’re also “free” (at the point of service) in the UK, but the scanner and helium are not a generous gift from the fey folk, nor does the Queen volunteer as a tech. These things cost money. Any study you do is going to have to cover expenses—-including their share of a temperamental, multimillion dollar machine (or find a way to dip into the same accounts that cover its clinical use).